Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 7/2016

12.11.2015 | Originalien

Disease activity, obesity, functional disability, and depression in patients with rheumatoid arthritis

Impact on lipid status, glycoregulation, and risk for coronary heart disease

verfasst von: Dr. P. Ostojic, MD, PhD, MHSM, D. Bartolovic

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study aims to estimate the impact of disease activity, obesity, functional disability, and depression on lipid status, glycoregulation, and risk for coronary heart disease (CHD) in patients with rheumatoid arthritis (RA).

Patients and methods

A total of 36 patients with RA (30 women and 6 men, mean age 54.9 years, mean disease duration 7.9 years) were included in this study. We estimated the impact of age, body mass index, disease activity [assessed by DAS28 index and C-reactive protein (CRP) value], functional ability (estimated using the HAQ disability index), and depression [assessed using the Beck Depression Inventory (BDI)] on glycoregulation, lipid status, and risk for CHD in our patients. Glycoregulation was assessed by measuring insulin resistance, insulin, and glucose in blood. Lipids tested in blood included total cholesterol, HDL and LDL cholesterol, and triglycerides (TG). The 10-year risk for CHD was estimated using the Framingham risk score.

Results

Of 36 patients, 11 (30.6 %) fulfilled the criteria for metabolic syndrome (MS). Ten of 11 patients (90.1 %) with MS have a 10-year risk for CHD greater than 10 % compared to only 3 of 25 patients (12 %) without MS (p = 0.0001). Patients with high disease activity had lower HDL values than patients with mild or moderate disease activity (1.4 vs. 1.7 mmol/l, p = 0.04). Significant correlations were observed between CRP level and insulinemia (ρ = 0.57, p = 0.003), as well as CRP level and the HOMA index (ρ = 0.59, p = 0.002). The body mass index (BMI) correlated significantly with total cholesterol (r = 0.46, p = 0.02), LDL (ρ = 0.41, p = 0.04), and TG (ρ = 0.65, p < 0.001) in blood. The HAQ-DI did not correlate either with parameters of glycoregulation or lipid status. There was a significant positive correlation between BDI and BMI (ρ = 0.60, p < 0.001).

Conculsion

Active RA is independently associated with decreased HDL cholesterol and increased insulin resistance. Obesity was found to be an independent risk factor for increased total cholesterol, LDL cholesterol, and TG. Depressed patients with RA tend to be overweight or obese and, therefore, have an unfavorable lipid profile.
Literatur
1.
Zurück zum Zitat Mutru O, Laakso M, Isomaki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77CrossRefPubMed Mutru O, Laakso M, Isomaki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77CrossRefPubMed
2.
Zurück zum Zitat Myllykangas-Luosujarvi R, Aho K, Kautiainen H et al (1995) Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 22:1065–1067PubMed Myllykangas-Luosujarvi R, Aho K, Kautiainen H et al (1995) Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 22:1065–1067PubMed
3.
Zurück zum Zitat Kaplan MJ (2006) Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 18:289–297CrossRefPubMed Kaplan MJ (2006) Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 18:289–297CrossRefPubMed
4.
Zurück zum Zitat Chung CP, Oeser A, Solus JF et al (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196:756–763CrossRefPubMed Chung CP, Oeser A, Solus JF et al (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196:756–763CrossRefPubMed
5.
Zurück zum Zitat Festa A, D’Agostino R Jr, Howard G et al (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42–47CrossRefPubMed Festa A, D’Agostino R Jr, Howard G et al (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42–47CrossRefPubMed
6.
Zurück zum Zitat Kiortsis DN, Mavridis AK, Vasakos S et al (2005) Effects of infliximab treatment on insulin resistance in with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 64:765–766CrossRefPubMed Kiortsis DN, Mavridis AK, Vasakos S et al (2005) Effects of infliximab treatment on insulin resistance in with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 64:765–766CrossRefPubMed
7.
Zurück zum Zitat Nurmohamed MT (2007) Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 3:845–852PubMedPubMedCentral Nurmohamed MT (2007) Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 3:845–852PubMedPubMedCentral
8.
Zurück zum Zitat Barth J, Schumacher M, Herrmann-Lingen C (2004) Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66:802–813CrossRefPubMed Barth J, Schumacher M, Herrmann-Lingen C (2004) Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66:802–813CrossRefPubMed
9.
Zurück zum Zitat Covic T, Cumming SR, Pallant JF et al (2012) Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 12:6CrossRefPubMedPubMedCentral Covic T, Cumming SR, Pallant JF et al (2012) Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 12:6CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Fries JF, Spitz P, Kraines RG et al (1980) Measurement of patient outcomes in arthritis. Arthritis Rheum 23:137–145CrossRefPubMed Fries JF, Spitz P, Kraines RG et al (1980) Measurement of patient outcomes in arthritis. Arthritis Rheum 23:137–145CrossRefPubMed
11.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53–63CrossRef Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53–63CrossRef
12.
Zurück zum Zitat n a (2002)Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III). Final report. Circulation 106:3143–3421 n a (2002)Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III). Final report. Circulation 106:3143–3421
13.
Zurück zum Zitat Wilson PW, D’Agostino RB, Levy D et al (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97(18):1837–1847CrossRefPubMed Wilson PW, D’Agostino RB, Levy D et al (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97(18):1837–1847CrossRefPubMed
14.
Zurück zum Zitat Cunha VR de, Brenol CV, Brenol JC et al (2012) Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand J Rheumatol 41(3):186–191CrossRefPubMed Cunha VR de, Brenol CV, Brenol JC et al (2012) Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand J Rheumatol 41(3):186–191CrossRefPubMed
15.
Zurück zum Zitat Chung CP, Oeser A, Solus JF et al (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196(2):756–763CrossRefPubMed Chung CP, Oeser A, Solus JF et al (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196(2):756–763CrossRefPubMed
16.
Zurück zum Zitat Andersson CX, Gustafson B, Hammarstedt A et al (2008) Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes Metab Res Rev 24:595–603CrossRefPubMed Andersson CX, Gustafson B, Hammarstedt A et al (2008) Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes Metab Res Rev 24:595–603CrossRefPubMed
17.
Zurück zum Zitat Panoulas VF, Metsios G, Pace AV et al (2008) Hypertension in rheumatoid arthritis. Rheumatology 47:1286–1298CrossRefPubMed Panoulas VF, Metsios G, Pace AV et al (2008) Hypertension in rheumatoid arthritis. Rheumatology 47:1286–1298CrossRefPubMed
18.
Zurück zum Zitat Kontny E, Plebanczyk M, Lisowska B et al (2012) Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network. Ann Rheum Dis 71:262–267CrossRefPubMed Kontny E, Plebanczyk M, Lisowska B et al (2012) Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network. Ann Rheum Dis 71:262–267CrossRefPubMed
19.
Zurück zum Zitat Ehling A, Schaffler A, Herfarth H et al (2006) The potential of adiponectin in driving arthritis. J Immunol 176:4468–4478CrossRefPubMed Ehling A, Schaffler A, Herfarth H et al (2006) The potential of adiponectin in driving arthritis. J Immunol 176:4468–4478CrossRefPubMed
20.
Zurück zum Zitat Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259(5091):87–91CrossRefPubMed Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259(5091):87–91CrossRefPubMed
21.
Zurück zum Zitat Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6):2548–2556CrossRefPubMed Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6):2548–2556CrossRefPubMed
22.
23.
Zurück zum Zitat Kitahara K, Kusunoki N, Kakiuchi T et al (2009) Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 378:218–223CrossRefPubMed Kitahara K, Kusunoki N, Kakiuchi T et al (2009) Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 378:218–223CrossRefPubMed
24.
Zurück zum Zitat Stofkova A (2009) Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 43:157–168PubMed Stofkova A (2009) Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 43:157–168PubMed
25.
Zurück zum Zitat Luk T, Malam Z, Marshall JC (2008) Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 83:804–816CrossRefPubMed Luk T, Malam Z, Marshall JC (2008) Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 83:804–816CrossRefPubMed
26.
Zurück zum Zitat Rabe K, Lehrke M, Parhofer KG et al (2008) Adipokines and insulin resistance. Mol Med 14(11–12):741–751 Rabe K, Lehrke M, Parhofer KG et al (2008) Adipokines and insulin resistance. Mol Med 14(11–12):741–751
27.
Zurück zum Zitat Yamauchi T, Nio Y, Maki T et al (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13(3):332–339CrossRefPubMed Yamauchi T, Nio Y, Maki T et al (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13(3):332–339CrossRefPubMed
29.
Zurück zum Zitat Amaro IF, Gonzalez FD, Junanatey CG et al (2011) Insulin resistance and rheumatoid arthritis. Rheumatol Clin 7(2):124–129 Amaro IF, Gonzalez FD, Junanatey CG et al (2011) Insulin resistance and rheumatoid arthritis. Rheumatol Clin 7(2):124–129
30.
Zurück zum Zitat Kim HJ, Higashimori T, Park SY et al (2004) Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53:1060–1067CrossRefPubMed Kim HJ, Higashimori T, Park SY et al (2004) Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53:1060–1067CrossRefPubMed
31.
Zurück zum Zitat Van der Poll T, Romijn JA, Endert E et al (1991) Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261:457–465 Van der Poll T, Romijn JA, Endert E et al (1991) Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261:457–465
32.
Zurück zum Zitat Pagano G, Bruno A, Cavallo-Perin P et al (1989) Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Arch Intern Med 149:1098–1101CrossRefPubMed Pagano G, Bruno A, Cavallo-Perin P et al (1989) Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Arch Intern Med 149:1098–1101CrossRefPubMed
33.
Zurück zum Zitat Dessein PH, Tobias M, Veller MG (2006) Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 33:2425–2432PubMed Dessein PH, Tobias M, Veller MG (2006) Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 33:2425–2432PubMed
34.
Zurück zum Zitat Swinkels D, Demacker P, Hendriks J et al (1989) Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis 9:604–613CrossRefPubMed Swinkels D, Demacker P, Hendriks J et al (1989) Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis 9:604–613CrossRefPubMed
35.
Zurück zum Zitat Robertson J, Peters MJ, McInnes IB et al (2013) Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol 9:513–23CrossRefPubMed Robertson J, Peters MJ, McInnes IB et al (2013) Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol 9:513–23CrossRefPubMed
36.
Zurück zum Zitat Gonzalez-Gay MJ, Gonzlaez-Juanatey C (2014) Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox. Ann Rheum Dis 73:1281–1283CrossRefPubMed Gonzalez-Gay MJ, Gonzlaez-Juanatey C (2014) Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox. Ann Rheum Dis 73:1281–1283CrossRefPubMed
37.
Zurück zum Zitat Georgiadis AN, Papavasiliou EC, Lourida ES et al (2006) Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment, a prospective, controlled study. Arthritis Res Ther 8:R82CrossRefPubMedPubMedCentral Georgiadis AN, Papavasiliou EC, Lourida ES et al (2006) Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment, a prospective, controlled study. Arthritis Res Ther 8:R82CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Corti MC, Salive ME, Guralnik JM (1996) Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol 49(5):519–526CrossRefPubMed Corti MC, Salive ME, Guralnik JM (1996) Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol 49(5):519–526CrossRefPubMed
39.
Zurück zum Zitat Frank RG, Beck NC, Parker JC et al (1988) Depression in rheumatoid arthritis. J Rheumatolol 15:920–925 Frank RG, Beck NC, Parker JC et al (1988) Depression in rheumatoid arthritis. J Rheumatolol 15:920–925
40.
Zurück zum Zitat Hawley DJ, Wolfe F (1988) Anxiety and depression in patients with rheumatoid arthritis: a prospective study of 400 patients. J Rheumatol 15(6):932–941PubMed Hawley DJ, Wolfe F (1988) Anxiety and depression in patients with rheumatoid arthritis: a prospective study of 400 patients. J Rheumatol 15(6):932–941PubMed
41.
Zurück zum Zitat Katz PP, Yelin EH (1995) The development of depressive symptoms among women with rheumatoid arthritis. Arthritis Rheum 38:49–56CrossRefPubMed Katz PP, Yelin EH (1995) The development of depressive symptoms among women with rheumatoid arthritis. Arthritis Rheum 38:49–56CrossRefPubMed
42.
Zurück zum Zitat Luppino FS, Wit LM de, Bouvy PF et al (2010) Overweight, obesity and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67(3):220–229CrossRefPubMed Luppino FS, Wit LM de, Bouvy PF et al (2010) Overweight, obesity and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67(3):220–229CrossRefPubMed
43.
Zurück zum Zitat Nichols M, Townsend N, Scarborough P et al (2014) Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 35:2950–2959CrossRefPubMed Nichols M, Townsend N, Scarborough P et al (2014) Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 35:2950–2959CrossRefPubMed
Metadaten
Titel
Disease activity, obesity, functional disability, and depression in patients with rheumatoid arthritis
Impact on lipid status, glycoregulation, and risk for coronary heart disease
verfasst von
Dr. P. Ostojic, MD, PhD, MHSM
D. Bartolovic
Publikationsdatum
12.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe 7/2016
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-015-1661-7

Weitere Artikel der Ausgabe 7/2016

Zeitschrift für Rheumatologie 7/2016 Zur Ausgabe

Update Rheumatologie

Update Rheumatologie

Wegbereiter der Rheumatologie

Kurt Seidel (1914–1990)

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.